FDA
- Status: approved
🇺🇸 bimatoprost 0.01% ophthalmic solution in United States
bimatoprost 0.01% ophthalmic solution (bimatoprost 0.01% ophthalmic solution) regulatory status in United States.
Marketing authorisation
bimatoprost 0.01% ophthalmic solution in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Frequently asked questions
Is bimatoprost 0.01% ophthalmic solution approved in United States?
Yes. FDA has authorised it.
Who is the marketing authorisation holder for bimatoprost 0.01% ophthalmic solution in United States?
Allergan is the originator. The local marketing authorisation holder may differ — check the official source linked above.